Unlisted Shares & OTC: Off-Exchange Investing Explained

Stock exchanges have rules - strict ones. Not every company can meet them, and not every company wants to.

Plenty of businesses choose to stay private, raising money by issuing shares directly to investors rather than listing on a public market.

So where do those shares sit from your perspective as an investor?

The answer involves something called OTC trading, and understanding it could save you from a costly mistake.

Let's get into it.

Listed vs Unlisted: Why Your Broker Shows Both

Most of the shares people buy and sell trade on a stock exchange, somewhere like the New York Stock Exchange, the Nasdaq, or the London Stock Exchange.

To get listed on one of these exchanges, a company has to meet strict requirements around its size, share price, financial reporting, and governance.

In exchange for meeting those standards, its shares get traded on a centralised platform where buyers and sellers are matched transparently and continuously.

But your broker doesn't only connect you to exchanges. It may also connect you to what's called the OTC market, short for over-the-counter, where shares trade outside of any centralised exchange entirely.

OTC stocks are shares that trade through a network of broker-dealers rather than on a formal exchange. Instead of a central order book matching buyers and sellers in real time, trades are arranged more directly, through intermediaries who quote prices and negotiate deals.

The result is a market that works differently, and carries different risks.

Why Some Companies Aren't On A Major Exchange

There are several reasons a company's shares might be available to buy without being listed on a major exchange.

Some are simply too small to meet listing requirements. Many OTC stocks are small or micro-cap companies that don't qualify for the major exchanges based on their size, share price, or shareholder base.

Some are foreign companies taking a lighter route to market. Rather than going through a full local exchange listing, certain overseas businesses make their shares available to investors in other countries through instruments like American Depositary Receipts, or ADRs, which trade OTC.

ADRs are US‑traded certificates issued by a US bank that represents shares of a non‑US company and allows those shares to trade in dollars on US markets.

Some were previously listed but got delisted. As we've covered before, companies can be removed from exchanges if they fall below minimum standards.

Those shares often continue to trade OTC even after that happens, which is one reason a delisting doesn't always mean you can't sell your shares, just that it becomes harder and riskier.

And increasingly, some are pre-IPO companies available through specialist platforms that let retail investors buy shares in private businesses before they go public.

These platforms are usually secondary markets for private shares rather than part of the formal OTC stock tiers, but from an investor’s perspective they can feel similar: you’re buying shares that aren’t listed on a major exchange.

Why These Shares Carry More Risk

The risks in OTC and unlisted markets are real.

The biggest issue? Transparency.

Many OTC companies have far less stringent disclosure obligations than exchange-listed companies, which means the financial information available to you as an investor is often limited, out of date, or hard to verify. Making good investment decisions is much harder without reliable data.

OTC markets are also more prone to fraud and manipulation.

Looser regulation and weaker oversight make them a breeding ground for pump-and-dump schemes, where a stock is artificially hyped to drive the price up before insiders sell, leaving other investors with losses.

Liquidity is another concern.

With fewer buyers and sellers, getting in and out of a position can be difficult. You might find yourself holding shares you can't sell, or only able to sell at a significantly lower price than you paid.

How OTC Trading Actually Works

Without a central exchange, OTC trading relies on broker-dealers and market makers who match buyers and sellers and quote prices.

This means the gap between what you can buy a share for and what you can sell it for, known as the bid-ask spread, tends to be wider than on a major exchange. You may also find it harder to get a trade executed quickly, or at the price you expected.

In the US, the OTC market has different tiers, ranging from relatively transparent and well-regulated companies at the top end, to very opaque penny stocks at the bottom. The lower down the tier, the less information is available and the higher the risk.

Not all brokers offer access to all OTC stocks, and some add warnings or restrictions for good reason.

If you do venture into this space, treat it as a small, high-risk addition to a robust core, not the foundation of your strategy.

What To Do With This Information

For most long-term, diversified investors, the core of a portfolio is best built on listed ETFs and mainstream stocks where transparency, regulation, and liquidity are significantly stronger.

That doesn't mean OTC or unlisted shares are always off-limits, but before buying anything outside a major exchange, a few questions are worth asking.

Do you understand why this company isn't listed? Is reliable financial information actually available? How easily could you sell if you needed to? And how large a position would this be relative to your overall portfolio?

If you do venture into this space, treat it as a small, high-risk addition to a robust core, not the foundation of your strategy. And be particularly sceptical of anything promising pre-IPO riches or "hidden gem" opportunities without solid, verifiable information to back it up.

If it sounds too good to be true in a market with less oversight, it usually is.